Jason Fuller

Jason Fuller

Corporate Officer/Principal presso
Massachusetts Institute of Technology
48 anni
Health Technology
Finance
Consumer Services

Profilo

Jason Fuller, Ph.D., is a Partner on the Therapeutics team and joined the Firm in 2021.
Prior to Deerfield, Dr. Fuller was an investor at New Enterprise Associates (NEA), where he co-managed several investments in therapeutics, as well as in tools and diagnostics.
Previous to NEA, he served as Head of Corporate Development at Jounce Therapeutics, one of several company formation projects he helped initiate in his role as Principal at Third Rock Ventures before joining Jounce.
Dr. Fuller holds a B.S.
in Chemical Engineering from Michigan State University, an M.Phil.
from Cambridge University, and a Ph.D.
in Chemical Engineering from the Massachusetts Institute of Technology, where he completed his degree in the lab of Robert Langer

Posizioni attive di Jason Fuller

SocietàPosizioneInizio
Corporate Officer/Principal 07/04/2011
Investitore di Private Equity 01/01/2014
Investitore di Private Equity 01/01/2021

Precedenti posizioni note di Jason Fuller

SocietàPosizioneFine
GALERA THERAPEUTICS, INC. Direttore/Membro del Consiglio 09/06/2020
Direttore/Membro del Consiglio -
JOUNCE THERAPEUTICS, INC. Fondatore -
SAGIMET BIOSCIENCES INC. Direttore/Membro del Consiglio -
3M COMPANY Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Jason Fuller

Formazione di Jason Fuller

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

97

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private12

Health Technology

Producer Manufacturing

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Finance

Health Technology

Health Technology

Finance

  1. Mercati
  2. Insiders
  3. Jason Fuller